Yishan Li
Executive Chairman, Director, 10% Owner · BlossomHill Therapeutics, Inc.
Individual
- 2026
- Aug 10, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Yishan Li files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- ORBIMED ADVISORS LLC - $10.00M in BLSM purchases and sales in the last 12 months
- Carl L. Gordon - $10.00M in BLSM purchases and sales in the last 12 months
- Bihua Chen - $5.00M in BLSM purchases and sales in the last 12 months
- John P. Schmid - $96K in BLSM purchases and sales in the last 12 months
- Vincent Paul Liptak - $75K in BLSM purchases and sales in the last 12 months
- Jason A. Keyes - $11K in BLSM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Yishan Li?
Yishan Li is a corporate insider, tracked as Executive Chairman, Director, 10% Owner of BlossomHill Therapeutics, Inc. (BLSM). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Yishan Li submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
